What is Noble Financial’s Estimate for GoHealth Q1 Earnings?

GoHealth, Inc. (NASDAQ:GOCO) – Noble Financial issued their Q1 2026 earnings estimates for shares of GoHealth in a research report issued to clients and investors on Thursday, April 2nd. Noble Financial analyst M. Kupinski forecasts that the company will earn ($2.49) per share for the quarter. Noble Financial has a “Strong-Buy” rating on the stock. The consensus estimate for GoHealth’s current full-year earnings is ($5.50) per share. Noble Financial also issued estimates for GoHealth’s Q2 2026 earnings at ($2.50) EPS, Q4 2026 earnings at ($1.58) EPS, FY2026 earnings at ($7.53) EPS and FY2027 earnings at ($4.12) EPS.

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of GoHealth in a report on Monday, December 29th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, GoHealth presently has an average rating of “Hold” and a consensus target price of $5.00.

GoHealth Price Performance

Shares of NASDAQ GOCO opened at $1.28 on Friday. The company has a market capitalization of $36.61 million, a PE ratio of -0.07 and a beta of 1.61. GoHealth has a twelve month low of $1.26 and a twelve month high of $11.88. The firm has a fifty day simple moving average of $1.73 and a 200 day simple moving average of $2.79.

GoHealth (NASDAQ:GOCO) last posted its quarterly earnings data on Tuesday, March 31st. The company reported ($1.03) EPS for the quarter, beating analysts’ consensus estimates of ($2.69) by $1.66. GoHealth had a negative net margin of 26.95% and a positive return on equity of 8.00%. The company had revenue of $12.64 million for the quarter, compared to analyst estimates of $88.62 million.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the business. Barclays PLC increased its position in shares of GoHealth by 10.1% during the fourth quarter. Barclays PLC now owns 81,181 shares of the company’s stock worth $175,000 after acquiring an additional 7,430 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in GoHealth by 119.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 26,448 shares of the company’s stock valued at $57,000 after purchasing an additional 14,388 shares during the last quarter. Deutsche Bank AG boosted its stake in GoHealth by 150.8% during the 4th quarter. Deutsche Bank AG now owns 32,183 shares of the company’s stock valued at $69,000 after purchasing an additional 19,349 shares during the last quarter. Goldman Sachs Group Inc. bought a new stake in GoHealth during the 4th quarter worth approximately $26,000. Finally, Geode Capital Management LLC increased its holdings in GoHealth by 8.1% during the 4th quarter. Geode Capital Management LLC now owns 150,821 shares of the company’s stock worth $324,000 after purchasing an additional 11,340 shares in the last quarter. 24.21% of the stock is currently owned by institutional investors and hedge funds.

GoHealth Company Profile

GoHealth, Inc is a technology-driven health insurance marketplace that connects consumers with a wide range of health insurance plans from leading carriers. Through its digital platform, the company facilitates the comparison, selection and enrollment process for individual and family plans, as well as Medicare Advantage and Medicare Supplement products. By leveraging data analytics and customer support services, GoHealth aims to simplify a traditionally complex market and enable more informed decision-making for policyholders.

The company’s online portal integrates real-time quoting tools, educational resources and access to licensed insurance agents, ensuring that users receive personalized guidance throughout the enrollment journey.